news Charles River Laboratories announces extended relationship with The Michael J. Fox Foundation 18 May 2018 | By Charles River Laboratories Extension includes new project to phenotype Parkinson’s disease models and the continuation of LRRK2 research.
whitepaper Whitepaper: In search of a disease-modifying agent for Parkinson’s disease: a discovery story 21 November 2017 | By Charles River Laboratories Are selective, brain-penetrant inhibitors of LRRK2 an answer?
news New drug could stop Parkinson’s Disease 20 July 2016 | By Niamh Louise Marriott, Digital Content Producer Scientists discovered an interaction in neurons that contributes to Parkinson's disease, showing how drugs now under development could block the process...